Previous Pause Next
Home >> News Center >>
Investment & Financials
Vertex CEO Chides Analyst In Front Of Investors PDF Print E-mail
Friday, 16 September 2011 00:27
Usually, investor conferences sponsored by investment banks are staid and exceedingly polite affairs where analysts diplomatically moderate the discussion and high-ranking execs work hard to stay on message.
Abbott Laboratories Builds Late-Stage Drug Pipeline With Deals PDF Print E-mail
Friday, 16 September 2011 00:21

Abbott Laboratories'  drug-discovery arm is focusing on fewer diseases, but it has more promising drug candidates than in recent years partly because of acquisitions and license deals, a top executive said.

Fosun Pharma to Pay $219 Million for 70% of Jinzhou Ahon PDF Print E-mail
Thursday, 15 September 2011 00:23

Fosun Pharma will pay up to $219 million to acquire a 70% stake in drugmaker Jinzhou Ahon Pharmaceutical; Fosun Pharma also announced a generic drug JV with Lonza Group of Switzerland, backed by $15.6 million of capital;

Tensha Therapeutics Emerges With $15 Million Funding PDF Print E-mail
Wednesday, 14 September 2011 00:53
Tensha Therapeutics announced today that it has raised $15 million in a Series A financing to advance the development of small molecule bromodomain inhibitors for the treatment of cancer and other conditions by regulating the transcription of disease-associated genes.
SuperGen, Inc. Changes Name to Astex Pharmaceuticals , Announces New Stock Ticker Symbol and New Website PDF Print E-mail
Wednesday, 14 September 2011 00:12
SuperGen, Inc. (NASDAQ: ASTX) announced that it has officially begun operating under the name Astex Pharmaceuticals, Inc. Concurrent with this new name, and effective at the start of trading today, September 12, 2011, the ticker symbol for the Company’s common stock listed on NASDAQ has changed from "SUPG" to "ASTX."
Pfizer Inc. and Guoyuan Form Joint Venture to Expand Development, Manufacture and Distribution of Animal Vaccines in China PDF Print E-mail
Tuesday, 13 September 2011 00:47
Pfizer Animal Health, a business unit of Pfizer Inc. (NYSE:PFE - News), and Jilin Guoyuan Animal Health Company, Ltd., an innovator in animal health vaccines based in Huinan, today announced an agreement to jointly develop, manufacture and distribute animal health vaccines in China.
Fosun Pharma Buys 70% of Jinzhou Ahon Pharma for $219 Million PDF Print E-mail
Monday, 12 September 2011 00:44
Shanghai Fosun Pharmaceutical (Group) will pay up to 1.4 billion RMB ($219 million) to acquire a 70% stake in Jinzhou Ahon Pharmaceutical Co., Ltd. A wholly-owned subsidiary, Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., will be the acquirer.
Theraclone Sciences, Inc. Snaps Up $10.6 Million Financing PDF Print E-mail
Monday, 12 September 2011 00:38
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced a $10.6 million extension to its Series B financing, bringing the total round to $41 million. Previous investors ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures and Zenyaku Kogyo participated in the financing.
Royalty Pharma Raises $3.6 Billion to Refinance $2.75 Billion of Outstanding Debt and to Fund an $850 Million Cash Distribution to Shareholders PDF Print E-mail
Saturday, 10 September 2011 00:13
Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully refinanced $2.75 billion of outstanding debt and funded a one-time $850 million cash distribution to shareholders.
Orphazyme Raises $19.6 Million in a Series A Financing Round PDF Print E-mail
Friday, 09 September 2011 00:52
Orphazyme ApS, a biopharmaceutical company which develops innovative treatments for a family of genetic disorders called lysosomal storage diseases, today announced the successful completion of a €14 million Series A financing round
Boehringer Ingelheim Corporation Sketches Out $382 Million Expansion Plan PDF Print E-mail
Friday, 16 September 2011 00:24

The economy may be sputtering but Boehringer Ingelheim's expansion plans appear to be moving smoothly forward, with an application for two new projects now before the Planning and Zoning Commission.

PharmaPros & OmniComm Systems, Inc. Announce Partnership Agreement PDF Print E-mail
Thursday, 15 September 2011 00:29
PharmaPros Corporation, a technology solutions provider specializing in business intelligence for clinical trials, announced today that OmniComm Systems, one of the fastest growing companies in the EDC marketplace, has entered into a strategic partnership agreement to offer PharmaPros' Dataflow Manager™ as a bundled solution with their flagship EDC product, TrialMaster®.
Geron to Webcast Presentations at Upcoming Investor Conferences PDF Print E-mail
Thursday, 15 September 2011 00:01
Geron Corporation (Nasdaq: GERN) today announced that management will present a company overview at two upcoming investor conferences.
  • Rodman & Renshaw Annual Global Investment Conference in New York City. David L. Greenwood, Geron’s President and Chief Executive Officer, will present at 9:35 a.m. EDT on Tuesday, September 13, 2011.
Novo Nordisk A/S - Share Repurchase Program PDF Print E-mail
Wednesday, 14 September 2011 00:21
Company Announcement no 57 2011:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc PDF Print E-mail
Tuesday, 13 September 2011 00:55
Enterologics, Inc (ELGO.OB) announced today that it has completed its acquisition of The BioBalance Corporation and its subsidiary BioBalance LLC from New York Health Care, Inc. ("NYHC"). With this purchase Enterologics acquired its first probiotic biotherapeutic product, E. coli M17, or Probactrix®.
GlaxoSmithKline Names Biochemist, Venture Capitalist to Lead its VC Unit PDF Print E-mail
Tuesday, 13 September 2011 00:46

Jens Eckstein has been named President of SR One, GSK’s independent healthcare venture organisation, effective 1 October.

Medicis Won't Sell Fat-buster in the US Despite FDA OK PDF Print E-mail
Monday, 12 September 2011 00:41

Medicis Pharmaceuticals Corp. said Thursday that the Food and Drug Administration approved marketing of its LipoSonix system, which uses ultrasound to destroy fat deposits in the stomach.

Dynavax Technologies Corporation Receives $600,000 SBIR Grant for TLR Research PDF Print E-mail
Saturday, 10 September 2011 00:16
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the receipt of a two-year Small Business Innovation Research grant (SBIR) for $600,000. The Award is provided by the National Institute of Allergy and Infectious Diseases and will be used to fund research to characterize the role of the phosphoinositide 3-kinase (PI3K) in preclinical models of skin autoimmune inflammation.
Innospec Initiates a $40 Million Share Repurchase Program PDF Print E-mail
Saturday, 10 September 2011 00:11
Innospec Inc. (Nasdaq:IOSP) today announced that its board of directors has approved an increase in the amount of shares that are subject to buy back under the company's stock repurchase program.
GlaxoSmithKline Gets $94 Million Contract for Antibiotic PDF Print E-mail
Friday, 09 September 2011 00:50
Anacor Pharmaceuticals /quotes/zigman/1553440/quotes/nls/anac ANAC +5.35% announced today that its partner, GlaxoSmithKline (GSK), has been awarded a contract with the U.S.
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 110